SCHEMBL5503660

SCHEMBL5503660

Cc1cc(C#N)cc(I)c1N.Cc1cc(C#N)ccc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.43
ALB P02768 1/20 0.43
ALDH1A1 P00352 4/20 0.37
CYP3A4 P08684 4/20 0.37
TDP1 Q9NUW8 3/20 0.37
TSHR P16473 2/20 0.37
EGLN2 Q96KS0 4/20 0.35
CYP2A6 P11509 1/20 0.34
SLC6A2 P23975 2/20 0.34
ABCC3 O15438 1/20 0.34
ESR1 P03372 1/20 0.34
CYP1A2 P05177 1/20 0.34
PGR P06401 1/20 0.34
CHRM2 P08172 1/20 0.34
ABCB1 P08183 1/20 0.34
ADRA2A P08913 1/20 0.34
CYP2D6 P10635 1/20 0.34
CHRM1 P11229 1/20 0.34
CYP2C9 P11712 1/20 0.34
DRD1 P21728 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2958367 0.88 TTR (0.54) TTRALBALDH1A1CYP3A4TDP1
SCHEMBL627108 0.84 CYP3A4 (0.50) ALDH1A1CYP3A4TDP1TSHREGLN2
SCHEMBL98131 0.78 TTR (0.48) TTRALBALDH1A1TSHREGLN2
Iodide SCHEMBL1704562 0.77 TTR (0.46) TTRALBALDH1A1TSHREGLN2
SCHEMBL22197816 0.74 TTR (0.58) TTRALBALDH1A1TSHRCHRM2
SCHEMBL1182463 0.74 ALDH1A1 (0.50) TTRALBALDH1A1CYP3A4TDP1
SCHEMBL171718 0.73 TTR (0.52) TTRALBALDH1A1TSHRCYP2A6
SCHEMBL2565697 0.73 TTR (0.46) TTRALBALDH1A1EGLN2CYP2A6
SCHEMBL2339085 0.73 ALDH1A1 (0.39) TTRALBALDH1A1CYP3A4TDP1
SCHEMBL31483658 0.73 TTR (0.46) TTRALBALDH1A1EGLN2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861357-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2007-12-05 EP disclosed
WO-2006101318-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-28 WO disclosed